ReShape Lifesciences Profile

2.05
USD 0.07  3.54%
0%
49%

Key Fundamentals

ReShape Lifesciences Against Markets

  The entity ReShape Lifesciences with a symbol ETRM was delisted from Nasdaq Capital Markets. Please use ReShape Lifesciences with a symbol RSLS from now on.

Diversify with ReShape Lifesciences

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ReShape Lifesciences to your portfolio

Directors

ReShape Lifesciences Corporate Directors
Nicholas Teti Independent Director
Carl Goldfischer Independent Director
Catherine Friedman Independent Director
Additionally see Investing Opportunities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.